Schroder Investment Management Group’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,317
Closed -$569K 1341
2022
Q3
$569K Hold
2,317
﹤0.01% 1118
2022
Q2
$595K Buy
2,317
+596
+35% +$161K ﹤0.01% 1156
2022
Q1
$565K Buy
1,721
+657
+62% +$202K ﹤0.01% 1205
2021
Q4
$382K Hold
1,064
﹤0.01% 1154
2021
Q3
$346K Hold
1,064
﹤0.01% 1257
2021
Q2
$332K Buy
1,064
+357
+50% +$110K ﹤0.01% 1272
2021
Q1
$225K Hold
707
﹤0.01% 1312
2020
Q4
$229K Hold
707
﹤0.01% 1286
2020
Q3
$185K Hold
707
﹤0.01% 1190
2020
Q2
$171K Hold
707
﹤0.01% 1110
2020
Q1
$106K Sell
707
-367
-34% -$60.9K ﹤0.01% 1183
2019
Q4
$183K Buy
1,074
+389
+57% +$72.1K ﹤0.01% 1171
2019
Q3
$120K Sell
685
-148
-18% -$32K ﹤0.01% 1179
2019
Q2
$217K Hold
833
﹤0.01% 1077
2019
Q1
$238K Buy
+833
New +$277K ﹤0.01% 1063
2018
Q3
Sell
-3,650
Closed -$1.51M 1354
2018
Q2
$1.51M Sell
3,650
-7,053
-66% -$2.56M ﹤0.01% 865
2018
Q1
$3.11M Sell
10,703
-162
-1% -$41.1K 0.01% 791
2017
Q4
$2.04M Sell
10,865
-2,419
-18% -$452K ﹤0.01% 895
2017
Q3
$2.16M Buy
13,284
+8,175
+160% +$1.24M ﹤0.01% 879
2017
Q2
$716K Buy
+5,109
New +$687K ﹤0.01% 1024

Other funds holding ABMD

Schroder Investment Management Group's ABMD Position: Q4 2022 in Review

Schroder Investment Management Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,317 shares — an estimated $569K sold.

Schroder Investment Management Group first reported a position in ABMD in Q2 2017 and held it in 20 quarters. The position peaked at $3.11M in Q1 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Schroder Investment Management Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Schroder Investment Management Group sold 2,317 Abiomed Inc shares in Q4 2022, an estimated $569K.
  • Schroder Investment Management Group first reported a position in Abiomed Inc in Q2 2017 and held it in 20 quarters.
  • Schroder Investment Management Group's Abiomed Inc position peaked at $3.11M in Q1 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Schroder Investment Management Group's 13F filing for Q4 2022, filed 10 Feb 2023.